AstraZeneca collaborates with Multiply Labs to scale cell therapy manufacturing using end-to-end GMP-ready robotic technology ...

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...

To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

Researchers at Johns Hopkins, writing in the journal Cell, have found that a single brain stem cell can produce two stem cells just like itself. "If we can somehow cash in on this newly discovered ...

Chloride ion flows that enter the cells play an important role in the duplication of glioblastoma cells, a highly aggressive brain tumor. This is the finding of research recently published in the ...

“Historically, cell and gene therapy manufacturing has been manual, almost artisanal," says Fred Parietti, CEO of Multiply Labs. "Expert scientists perform hundreds of tasks by hand, from pipetting to ...